Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINLESS: ESP Block in Medical Thoracoscopy
NCT06313632Phase 3Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Icahn School of Medicine at Mount Sinai. Started Mar 2024; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06313632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06313632.